nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Constipation—Thiotepa—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Pain—Thiotepa—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Discomfort—Fluorouracil—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Verteporfin—Back pain—Etoposide—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Oedema—Gemcitabine—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Verteporfin—Oedema—Fluorouracil—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Verteporfin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Skin disorder—Gemcitabine—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Verteporfin—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Verteporfin—Anaemia—Etoposide—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Verteporfin—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Verteporfin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Verteporfin—Discomfort—Cisplatin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Verteporfin—Urticaria—Thiotepa—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Verteporfin—Malaise—Etoposide—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Vertigo—Etoposide—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Oedema—Cisplatin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Verteporfin—Loss of consciousness—Etoposide—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Verteporfin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Cough—Etoposide—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Skin disorder—Cisplatin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Hypertension—Etoposide—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Chest pain—Etoposide—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Discomfort—Etoposide—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Pain—Gemcitabine—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Constipation—Gemcitabine—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Asthenia—Thiotepa—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Verteporfin—Influenza—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Pruritus—Thiotepa—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Pain—Fluorouracil—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Skin disorder—Etoposide—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Verteporfin—Pain—Cisplatin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Verteporfin—Dizziness—Thiotepa—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Verteporfin—Urticaria—Fluorouracil—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Verteporfin—Sweating—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Dyspnoea—Etoposide—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Rash—Thiotepa—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Dermatitis—Thiotepa—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Headache—Thiotepa—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Verteporfin—Pain—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Verteporfin—Constipation—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Verteporfin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Sweating—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Asthenia—Gemcitabine—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Pruritus—Gemcitabine—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Nausea—Thiotepa—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Verteporfin—Feeling abnormal—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Pruritus—Fluorouracil—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Verteporfin—Urticaria—Etoposide—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Body temperature increased—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Asthenia—Cisplatin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Dizziness—Fluorouracil—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Rash—Gemcitabine—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Headache—Gemcitabine—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Flushing—Epirubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Rash—Fluorouracil—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Headache—Fluorouracil—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Asthenia—Etoposide—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Back pain—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Pruritus—Etoposide—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Nausea—Gemcitabine—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Rash—Cisplatin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Dermatitis—Cisplatin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Nausea—Fluorouracil—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Back pain—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Malaise—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Dizziness—Etoposide—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Nausea—Cisplatin—urinary bladder cancer	0.000994	0.000994	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—urinary bladder cancer	0.000993	0.000993	CcSEcCtD
Verteporfin—Cough—Methotrexate—urinary bladder cancer	0.000982	0.000982	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000977	0.000977	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000975	0.000975	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—urinary bladder cancer	0.000974	0.000974	CcSEcCtD
Verteporfin—Rash—Etoposide—urinary bladder cancer	0.000967	0.000967	CcSEcCtD
Verteporfin—Dermatitis—Etoposide—urinary bladder cancer	0.000966	0.000966	CcSEcCtD
Verteporfin—Headache—Etoposide—urinary bladder cancer	0.000961	0.000961	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—urinary bladder cancer	0.000958	0.000958	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—urinary bladder cancer	0.000958	0.000958	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
Verteporfin—Malaise—Epirubicin—urinary bladder cancer	0.00095	0.00095	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—urinary bladder cancer	0.000947	0.000947	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—urinary bladder cancer	0.000946	0.000946	CcSEcCtD
Verteporfin—Syncope—Epirubicin—urinary bladder cancer	0.000945	0.000945	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000926	0.000926	CcSEcCtD
Verteporfin—Cough—Epirubicin—urinary bladder cancer	0.000919	0.000919	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000919	0.000919	CcSEcCtD
Verteporfin—Nausea—Etoposide—urinary bladder cancer	0.000911	0.000911	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—urinary bladder cancer	0.00091	0.00091	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000904	0.000904	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—urinary bladder cancer	0.000901	0.000901	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—urinary bladder cancer	0.000897	0.000897	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—urinary bladder cancer	0.000897	0.000897	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000891	0.000891	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000888	0.000888	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—urinary bladder cancer	0.000886	0.000886	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—urinary bladder cancer	0.000879	0.000879	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—urinary bladder cancer	0.000874	0.000874	CcSEcCtD
Verteporfin—Oedema—Epirubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Verteporfin—Cough—Doxorubicin—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Verteporfin—Shock—Epirubicin—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000843	0.000843	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—urinary bladder cancer	0.000842	0.000842	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000837	0.000837	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—urinary bladder cancer	0.000835	0.000835	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000831	0.000831	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—urinary bladder cancer	0.00083	0.00083	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—urinary bladder cancer	0.00083	0.00083	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—urinary bladder cancer	0.00082	0.00082	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000819	0.000819	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—urinary bladder cancer	0.000796	0.000796	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000793	0.000793	CcSEcCtD
Verteporfin—Pain—Methotrexate—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000783	0.000783	CcSEcCtD
Verteporfin—Shock—Doxorubicin—urinary bladder cancer	0.000783	0.000783	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00078	0.00078	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000769	0.000769	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000767	0.000767	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000757	0.000757	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Verteporfin—Pain—Epirubicin—urinary bladder cancer	0.000735	0.000735	CcSEcCtD
Verteporfin—Constipation—Epirubicin—urinary bladder cancer	0.000735	0.000735	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000726	0.000726	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000725	0.000725	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000687	0.000687	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—urinary bladder cancer	0.000683	0.000683	CcSEcCtD
Verteporfin—Pain—Doxorubicin—urinary bladder cancer	0.00068	0.00068	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—urinary bladder cancer	0.00068	0.00068	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—urinary bladder cancer	0.00068	0.00068	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—urinary bladder cancer	0.000659	0.000659	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000656	0.000656	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—urinary bladder cancer	0.00065	0.00065	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000629	0.000629	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—urinary bladder cancer	0.000617	0.000617	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Verteporfin—Rash—Methotrexate—urinary bladder cancer	0.000579	0.000579	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—urinary bladder cancer	0.000579	0.000579	CcSEcCtD
Verteporfin—Headache—Methotrexate—urinary bladder cancer	0.000576	0.000576	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—urinary bladder cancer	0.000571	0.000571	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—urinary bladder cancer	0.000569	0.000569	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—urinary bladder cancer	0.000563	0.000563	CcSEcCtD
Verteporfin—Nausea—Methotrexate—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Verteporfin—Rash—Epirubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Verteporfin—Headache—Epirubicin—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—urinary bladder cancer	0.000526	0.000526	CcSEcCtD
Verteporfin—Nausea—Epirubicin—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Verteporfin—Rash—Doxorubicin—urinary bladder cancer	0.000502	0.000502	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000501	0.000501	CcSEcCtD
Verteporfin—Headache—Doxorubicin—urinary bladder cancer	0.000498	0.000498	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—urinary bladder cancer	0.000473	0.000473	CcSEcCtD
